Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia Hemostemix and Firefly will study brain wave ...

For more information on the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH), please click here. The ATEV is an investigational product and has not been ...

-Trial results are intended to support Biologics License Application (BLA) planned for fourth quarter 2023- DURHAM, N.C., July 26, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (HUMA), a clinical-stage ...

Purpose Glioblastoma is an incurable solid tumor characterized by increased expression of vascular endothelial growth factor (VEGF). We performed a phase II study of cediranib in patients with ...

CRESSKILL, NJ / ACCESSWIRE / August 5, 2024 / Vascular Therapies, a biotechnology company focused on improving vascular access outcomes in patients with kidney disease, today announced completion of ...

Real-world analyses to evaluate the role of TIGIT as a target in first-line (1L) gastric, gastroesophageal junction, and esophageal adenocarcinomas (GC/GEJC/EAC). This is an ASCO Meeting Abstract from ...